217 related articles for article (PubMed ID: 25750168)
1. FDA/DEA/PDMP/UDT: alphabet soup or sensible and integrated risk management?
Passik SD; Kirsh KL; Twillman RK
J Opioid Manag; 2015; 11(1):77-81. PubMed ID: 25750168
[TBL] [Abstract][Full Text] [Related]
2. Using urine drug testing to support healthy boundaries in clinical care.
Heit HA; Gourlay DL
J Opioid Manag; 2015; 11(1):7-12. PubMed ID: 25750160
[TBL] [Abstract][Full Text] [Related]
3. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management.
Reisfield GM; Goldberger BA; Bertholf RL
J Opioid Manag; 2015; 11(1):37-44. PubMed ID: 25750163
[TBL] [Abstract][Full Text] [Related]
4. A leader in the field...
DeVito RA
J Opioid Manag; 2015; 11(1):6. PubMed ID: 25881374
[No Abstract] [Full Text] [Related]
5. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
[TBL] [Abstract][Full Text] [Related]
6. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
[TBL] [Abstract][Full Text] [Related]
7. Immunoassay in healthcare testing applications.
DePriest AZ; Black DL; Robert TA
J Opioid Manag; 2015; 11(1):13-25. PubMed ID: 25750161
[TBL] [Abstract][Full Text] [Related]
8. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.
McCarberg BH
Postgrad Med; 2011 Nov; 123(6):124-31. PubMed ID: 22104461
[TBL] [Abstract][Full Text] [Related]
9. Drug testing and adherence monitoring in pain management: Oral fluid testing.
Moore C
J Opioid Manag; 2015; 11(1):69-75. PubMed ID: 25750167
[TBL] [Abstract][Full Text] [Related]
10. Urine drug testing: current recommendations and best practices.
Owen GT; Burton AW; Schade CM; Passik S
Pain Physician; 2012 Jul; 15(3 Suppl):ES119-33. PubMed ID: 22786451
[TBL] [Abstract][Full Text] [Related]
11. Urine drug testing in chronic pain.
Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
[TBL] [Abstract][Full Text] [Related]
12. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
Gupta A; Patton C; Diskina D; Cheatle M
Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
[TBL] [Abstract][Full Text] [Related]
13. Chronic pain: reducing costs through early implementation of adherence testing and recognition of opioid misuse.
McCarberg BH
Postgrad Med; 2011 Nov; 123(6):132-9. PubMed ID: 22104462
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
Manchikanti L; Malla Y; Wargo BW; Fellows B
Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
[TBL] [Abstract][Full Text] [Related]
15. Specimen validity testing in urine drug monitoring of medications and illicit drugs: clinical implications.
Kirsh KL; Christo PJ; Heit H; Steffel K; Passik SD
J Opioid Manag; 2015; 11(1):53-9. PubMed ID: 25750165
[TBL] [Abstract][Full Text] [Related]
16. Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?
Chakravarthy K; Goel A; Jeha GM; Kaye AD; Christo PJ
Curr Pain Headache Rep; 2021 Feb; 25(2):12. PubMed ID: 33598816
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing.
Manchikanti L; Malla Y; Wargo BW; Fellows B
Pain Physician; 2011; 14(3):259-70. PubMed ID: 21587329
[TBL] [Abstract][Full Text] [Related]
18. Urine Spiking in a Pain Medicine Clinic: An Attempt to Simulate Adherence.
Lee D; Bazydlo LA; Reisfield GM; Goldberger BA
Pain Med; 2015 Jul; 16(7):1449-51. PubMed ID: 25522892
[No Abstract] [Full Text] [Related]
19. Urine drug testing for pain management.
Magnani B; Kwong T
Clin Lab Med; 2012 Sep; 32(3):379-90. PubMed ID: 22939297
[TBL] [Abstract][Full Text] [Related]
20. Laboratory-Generated Urine Toxicology Interpretations: A Mixed Methods Study.
Chua IS; Ransohoff JR; Ehrlich O; Katznelson E; Virk ZM; Demetriou CA; Petrides AK; Orav EJ; Schiff GD; Melanson SEF
Pain Physician; 2021 Mar; 24(2):E191-E201. PubMed ID: 33740356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
